Gyre Therapeutics Inc (GYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 0 | 6 | 1,018 | 399 | 1,750 |
| Gross Profit | N/A | 6 | 1,018 | 399 | 1,750 |
| Operating Expenses | 57,277 | 33,828 | 22,840 | 20,817 | 15,552 |
| Operating Income | -57,277 | -33,822 | -21,822 | -20,418 | -13,802 |
| Interest Expense | 0 | 0 | 0 | 0 | 1,478 |
| Other Income | 2,099 | 3,767 | 261 | 3,473 | 518 |
| Pre-tax Income | -55,178 | -30,055 | -21,561 | -16,945 | -14,762 |
| Net Income Continuous | -55,178 | -30,055 | -21,561 | -16,945 | -14,762 |
| Net Income | $-55,178 | $-30,055 | $-21,561 | $-16,945 | $-14,762 |
| EPS Basic Total Ops | -68.97 | -40.18 | -111.69 | -326.09 | -749.48 |
| EPS Basic Continuous Ops | -68.92 | -40.18 | -94.41 | -326.12 | -750.24 |
| EPS Diluted Total Ops | -68.97 | -40.18 | -111.69 | -326.09 | -749.48 |
| EPS Diluted Continuous Ops | -68.92 | -40.18 | -94.41 | -326.12 | -750.24 |
| EPS Diluted Before Non-Recurring Items | -68.97 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-57,131 | $-33,673 | $-21,649 | $-20,029 | $-13,332 |